Common Contracts

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].”

Exclusive License Agreement • November 8th, 2019 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations

• Contract Type
  Exclusive License Agreement
• Filed
  November 8th, 2019
• Company
  Tonix Pharmaceuticals Holding Corp.
• Industry
  Pharmaceutical preparations

This Agreement is dated September 19, 2019 (the “Effective Date”), and is between THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, a New York corporation (“Columbia”), and TONIX PHARMACEUTICALS, INC., a Delaware corporation (“Company” or “Tonix”). Columbia and Company agree as follows:

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***].” EXCLUSIVE LICENSE AGREEMENT

Exclusive License Agreement • August 12th, 2019 • Tonix Pharmaceuticals Holding Corp. • Pharmaceutical preparations

• Contract Type
  Exclusive License Agreement
• Filed
  August 12th, 2019
• Company
  Tonix Pharmaceuticals Holding Corp.
• Industry
  Pharmaceutical preparations

This Agreement is dated May 20, 2019 (the “Effective Date”), and is between THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, a New York corporation (“Columbia”), and TONIX PHARMACEUTICALS HOLDING CORP., a Nevada corporation (“Company” or “Tonix”).